NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 238 filers reported holding NEOGENOMICS INC in Q1 2019. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $476,000 | -81.7% | 13,956 | -74.1% | 0.00% | -83.3% |
Q3 2021 | $2,603,000 | +122.9% | 53,968 | +108.8% | 0.01% | +100.0% |
Q2 2021 | $1,168,000 | -80.6% | 25,850 | -79.3% | 0.00% | -78.6% |
Q1 2021 | $6,010,000 | -22.9% | 124,600 | -14.0% | 0.01% | -12.5% |
Q4 2020 | $7,796,000 | +312.1% | 144,800 | +182.3% | 0.02% | +220.0% |
Q3 2020 | $1,892,000 | +91.1% | 51,300 | +60.5% | 0.01% | +66.7% |
Q2 2020 | $990,000 | +53.7% | 31,962 | +37.2% | 0.00% | -25.0% |
Q1 2020 | $644,000 | -27.7% | 23,290 | -23.6% | 0.00% | 0.0% |
Q4 2019 | $891,000 | +84.1% | 30,473 | +20.5% | 0.00% | +33.3% |
Q3 2019 | $484,000 | -75.3% | 25,293 | -71.7% | 0.00% | -76.9% |
Q2 2019 | $1,963,000 | +209.1% | 89,496 | +188.3% | 0.01% | +225.0% |
Q1 2019 | $635,000 | +247.0% | 31,048 | +113.7% | 0.00% | +300.0% |
Q4 2018 | $183,000 | -78.8% | 14,532 | -74.2% | 0.00% | -66.7% |
Q3 2018 | $865,000 | – | 56,327 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |